Compare Relay Therapeutics Inc. Common Stock (RLAY) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Relay Therapeutics Inc. Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Relay Therapeutics Inc. Common Stock trades at $18.14 (market cap $3.82B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.7 (market cap $2.27B). The key difference: Relay Therapeutics Inc. Common Stock is the larger of the two by market cap, and Relay Therapeutics Inc. Common Stock is more actively traded (4,332,079 versus 4,179,659). Which is the better fit depends on your goals.
| RLAY | SLS | |
|---|---|---|
Market Cap | $3.82B | $2.27B |
Volume | 4,332,079 | 4,179,659 |
Sector | Health | Health |
52-Week High | $20.75 | $15.46 |
52-Week Low | $6.03 | $1.39 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $2.93B | $2.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
